State Street’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-501,532
| Closed | -$2.32M | – | 3876 |
|
|
2019
Q1 | $2.32M | Buy |
501,532
+33,411
| +7% | +$158K | ﹤0.01% | 3100 |
|
|
2018
Q4 | $1.64M | Sell |
468,121
-20,909
| -4% | -$145K | ﹤0.01% | 3194 |
|
|
2018
Q3 | $4.93M | Buy |
489,030
+48,214
| +11% | +$385K | ﹤0.01% | 2873 |
|
|
2018
Q2 | $3.19M | Sell |
440,816
-7,865
| -2% | -$54.8K | ﹤0.01% | 3065 |
|
|
2018
Q1 | $2.71M | Sell |
448,681
-6,540
| -1% | -$54K | ﹤0.01% | 3048 |
|
|
2017
Q4 | $4.38M | Sell |
455,221
-18,960
| -4% | -$124K | ﹤0.01% | 2851 |
|
|
2017
Q3 | $4.21M | Buy |
474,181
+2,667
| +0.6% | +$27.5K | ﹤0.01% | 2877 |
|
|
2017
Q2 | $5.97M | Buy |
471,514
+15,570
| +3% | +$184K | ﹤0.01% | 2655 |
|
|
2017
Q1 | $4.79M | Buy |
455,944
+7,355
| +2% | +$78.4K | ﹤0.01% | 2715 |
|
|
2016
Q4 | $4.13M | Sell |
448,589
-784,731
| -64% | -$8.87M | ﹤0.01% | 2791 |
|
|
2016
Q3 | $14.5M | Buy |
1,233,320
+187,473
| +18% | +$2.85M | ﹤0.01% | 1982 |
|
|
2016
Q2 | $13.5M | Sell |
1,045,847
-400,976
| -28% | -$5.84M | ﹤0.01% | 2027 |
|
|
2016
Q1 | $23.1M | Buy |
1,446,823
+244,999
| +20% | +$4.65M | ﹤0.01% | 1626 |
|
|
2015
Q4 | $34.4M | Buy |
1,201,824
+155,741
| +15% | +$4.31M | ﹤0.01% | 1370 |
|
|
2015
Q3 | $29.8M | Sell |
1,046,083
-33,532
| -3% | -$1.23M | ﹤0.01% | 1485 |
|
|
2015
Q2 | $38.8M | Buy |
1,079,615
+56,347
| +6% | +$1.76M | ﹤0.01% | 1413 |
|
|
2015
Q1 | $29.7M | Buy |
1,023,268
+768,604
| +302% | +$20.3M | ﹤0.01% | 1559 |
|
|
2014
Q4 | $5.37M | Buy |
254,664
+9,692
| +4% | +$192K | ﹤0.01% | 2530 |
|
|
2014
Q3 | $4.75M | Buy |
244,972
+26,040
| +12% | +$409K | ﹤0.01% | 2573 |
|
|
2014
Q2 | $3.42M | Sell |
218,932
-53,256
| -20% | -$861K | ﹤0.01% | 2794 |
|
|
2014
Q1 | $5.64M | Buy |
272,188
+21,799
| +9% | +$432K | ﹤0.01% | 2509 |
|
|
2013
Q4 | $3.23M | Buy |
250,389
+91,686
| +58% | +$1.27M | ﹤0.01% | 2827 |
|
|
2013
Q3 | $1.85M | Buy |
+158,703
| New | +$1.3M | ﹤0.01% | 3078 |
|
Other funds holding INSY
WS
State Street's INSY Position: Q2 2019 in Review
State Street sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 501,532 shares — an estimated $2.32M sold.
State Street first reported a position in INSY in Q3 2013 and held it in 23 quarters. The position peaked at $38.8M in Q2 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- State Street reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- State Street sold 501,532 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $2.32M.
- State Street first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 23 quarters.
- State Street's Insys Therapeutics, Inc. position peaked at $38.8M in Q2 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on State Street's 13F filing for Q2 2019, filed 14 Aug 2019.